PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Subdivisions of Program Areas, these track general higher level sub-classifications of expenditure.
Subdivisions of Major categories, these are the most detailed expenditure data.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2008
This activity links directly with JHPIEGO, Population Services International/Society for Family Health
(PSI/SFH), and indirectly with USAID | DELIVER PROJECT's ARV Drug activity, the Partnership for Supply
Chain Management Systems' (SCMS) activities in Laboratory Strengthening, and Policy Analysis/Systems
For FY 2007 Plus-Up funds were used to serve as a bridging activity in the area of supply chain support for
the implementation of a national program to support male circumcision (MC) as part of the prevention of
HIV/AIDS. Through SCMS, Plus-Up funds assisted US Government (USG) projects and the Ministry of
Health (MOH) ensure that the necessary MC kits were available at chosen sites. Previously SFH and
JHPIEGO were procuring the different commodities needed to make up an MC kit in limited quantities.
These kits were provided to the chosen facilities.
The key activities during the bridging activity in FY 2007 included sending staff to the different national
meetings focused on MC to ensure that supply chain issues are addressed as the program expanded. A
national quantification exercise was conducted to determine the commodity quantity needs and costs.
SCMS staff monitored the supply situation of MC kit products at the Ministry of Health's (MOH) central
medical stores, Medical Stores Limited (MSL), and reported back to the different partners on product
Quantification of both the MC needs for these products and the general health needs will continue to be a
challenge in FY 2008. It will also be important to determine if there are ample supplies of kit commodities to
supply health facilities on a timely basis using the existing MSL managed distribution system. For most
MOH sites, the commodities that would make up an MC kit would be ordered from Medical Stores Limited
as part of their essential drug order. However, as with essential drugs, the system in place suffers from a
lack of sufficient funding and the lack of effective information and inventory control systems to manage the
actual needs of the health sites.
With FY 2008 funding, SCMS will review the pricing of the different products in a kit and determine the most
cost efficient manner to procure these products as the scale-up of the national program warrants larger
USG support for commodity purchases. In FY 2008 there will also be the need to conduct more field visits
to ascertain the stock situation at the facilities. Another key activity will be to develop a national logistics
strategic plan for the support of MC activities. This plan will become more important as more organizations
begin supporting MC activities throughout the nation.
Of the $9 million Plus-Up funding allotted to Zambia in August 2007, this activity will receive an additional
$1.4 million for the procurement of sexual transmitted infection (STI) drugs to treat herpes, syphilis,
gonorrhea, and chlamydia, which are the most common STIs in Zambia, and the most critical to treat for
HIV/AIDS prevention. Possible drugs to be procured include: Ciprofloxacin, Acyclovir, Erythromycin,
Doxycycline, Benzathine penicillin, and others pending final discussion with partners and the MOH.
All FY 2008 targets will be reached by September 30, 2009.
This activity links directly with USAID | DELIVER PROJECT's ARV Drug activity, the Partnership for Supply
Chain Management Systems' (SCMS) activities in Counseling and Testing (CT), Laboratory Strengthening,
and Policy Analysis/Systems Strengthening, Center for Infectious Diseases Research in Zambia, Catholic
Relief Services/AIDS Relief, Churches Health Association of Zambia (CHAZ), University Teaching Hospital
(UTH), Zambia Prevention, Care, and Treatment Partnership (ZPCT), Global Fund for AIDS, Tuberculosis
and Malaria (GFATM), the Clinton Foundation HIV/AIDS Initiative, and UNITAID.
The purpose of this activity is to develop a national forecast and procurement plan and to procure Co-
trimoxazole drugs in support of the Government of the Republic of Zambia's (GRZ) national ART program:
cotrimoxazole is used both as a prophylaxis and as a treatment for opportunistic infections. Following WHO
recommended guidelines, Zambia has adopted the policy of adding cotrimoxazole to the new national ART
guidelines which have been disseminated by the National HIV/AIDS/STI/TB Council (NAC). This
commodity will be added to the national ARV ordering and reporting system to better ensure its availability
for ART patients. In FY 2008, roughly 52,000 adult patients will receive cotrimoxazole (pediatric
cotrimoxazole is being provided by the Clinton Foundation with UNITAID funding).
Finally, it should be noted that as with USG-funded ARV drugs, the cotrimoxazole will be placed in the
GRZ's central warehouse, Medical Stores Limited (MSL), where all public sector and accredited
NGO/FBO/CBO/work-place/private sector ART programs will have access to these critical supplies. All
PEPFAR partners are connected to the national ARV logistics system.
All FY 2008 results will be achieved by September 30, 2009.
This activity links directly with all other Partnership for Supply Chain Management System activities; as well
as: The USAID | DELIVER PROJECT; Center for Infectious Disease Research in Zambia (CIDRZ); Catholic
Relief Services/AIDS Relief; Churches Health Association of Zambia; University Teaching Hospital; Zambia
Prevention, Care and Treatment Partnership (ZPCT); Population Services International/Society for Family
Health (SFH); Catholic Relief Services/SUCCESS; Zambia VCT Services; Global Fund for AIDS,
Tuberculosis and Malaria (GFATM); UNITAID; and the Clinton Foundation HIV/AIDS Initiative.
The purpose of this activity is to procure HIV test kits in support of the Government of the Republic of
Zambia's (GRZ) counseling and testing (CT), prevention of mother to child transmission (PMTCT), and
diagnostic testing programs. In FY 2007, the USAID | DELIVER Project provided support in strengthening
the national HIV test kit forecasting, quantification, and procurement systems, while the U.S. Government
(USG) through SCMS purchased $4 million worth of HIV test kits for the national program in accordance
with GRZ and USG rules and regulations.
In FY 2008, USG will continue its strong collaboration with GRZ, GFATM, Japan International Cooperative
Agency (JICA), and the Clinton Foundation/UNITAID to assist the national HIV testing programs in fulfilling
demand for these services. On behalf of the USG, SCMS will purchase three types of test kits for various
testing procedures based on the GRZ's 2006 revised HIV testing algorithm: screening (Determine),
confirmatory (Unigold), and tie-breaker (Bioline). All three tests are non-cold chain HIV rapid tests that
enhance the overall accessibility and availability of HIV testing in Zambia.
Furthermore, USG-funded HIV test kits will be placed in the GRZ's central warehouse, Medical Stores
Limited (MSL), where all the public sector and accredited NGO/FBO/CBO HIV testing programs will have
access to these critical supplies. It is anticipated that over 1,200 testing sites will be accessing these
donated supplies in 2008 and 2009. In 2009, USG's HIV test kit contribution will allow for approximately
1,800,000 tests or 70 percent of all HIV tests conducted. In collaboration with the aforementioned partners,
approximately 1,000,000 persons will be tested nationally in FY 2008.
All FY 2008 targets will be reached by September 30, 2009.
This activity links directly with Project USAID | DELIVER PROJECT's ARV Drug activity, the Partnership for
Supply Chain Management Systems' (SCMS) activities in Counseling and Testing (CT), Laboratory
Strengthening, and Policy Analysis/Systems Strengthening, Center for Infectious Diseases Research in
Zambia, Catholic Relief Services/AIDS Relief, Churches Health Association of Zambia (CHAZ), University
Teaching Hospital (UTH), Zambia Prevention, Care and Treatment Partnership (ZPCT), Global Fund for
AIDS, Tuberculosis and Malaria (GFATM), UNITAID and the Clinton Foundation HIV/AIDS Initiative.
The purpose of this activity is to procure ARV drugs in support of the Government of the Republic of
Zambia's (GRZ) national ART program. In FY 2007, USAID | DELIVER PROJECT provided assistance in
strengthening the national ARV drug forecasting, quantification, and procurement systems. With their
support, the US Government (USG) purchased $19 million worth of ARV drugs for the national program in
accordance with GRZ and USG rules and regulations.
In FY 2008, the USG will continue its strong collaboration with GRZ, GFATM, UNITAID and the Clinton
Foundation to assist the national ART programs in fulfilling demand for ART services. On behalf of the
USG, SCMS will purchase the following drugs: lamivudine (3TC), zidovudine (AZT) 100mg, AZT/3TC,
didanosine (ddI) 100mg, efavirenz (EFV) 200mg, EFV 600mg, nelfinavir (NFV) 250mg, NLF LPV/r133/33
caps, nevirapine 200mg, Tenofovir, Tenofovir/Emtricitabine and Tenofovir/Lamivudine; pediatric specific
drugs will include LPV/r syrup, and ddI 50mg.
Purchases will change as: 1) additional ARV drugs are approved by the Food and Drug Administration
(FDA) and registered in Zambia; 2) the GFATM and Clinton Foundation ARV drug donations become
solidified; and, 3) the GRZ makes changes to the national ARV treatment protocols. It is estimated that
approximately two percent of the total budget will be used to procure pediatric ARV drugs; this figure is
based on the UNITAID/Clinton Foundation's commitment to provide all required pediatric first line
formulations during this time period. An estimated three percent will be used to support PMTCT programs;
however, this figure is difficult to fix as PMTCT drugs are used in general ART.
Furthermore, USG-funded ARV drugs will be placed in the GRZ's central warehouse, Medical Stores
Limited, where all public sector and accredited NGO/FBO/CBO/work-place/private sector ART programs will
have access to these critical supplies. It is estimated that USG procurements, in combination with GFATM
and Clinton Foundation purchases, will enable Zambia to place 230,000 patients on ART by the end of
2009. The cost per patient is estimated at $36/month based on the new national treatment protocols
enacted at the end of 2007.
All FY 2008 results will be reached by September 30, 2009.
This activity links with the Partnership for Supply Chain Management System's (SCMS) activities in ARV
Drug procurement, Counseling and Testing (CT), and Policy Analysis/Systems Strengthening; USAID |
DELIVER PROJECT activities in ARV Drugs and CT; the Centers for Disease Control and Prevention;
Center for Infectious Diseases Research in Zambia ; Catholic Relief Services/AIDS Relief; Churches Health
Association of Zambia; Zambia Prevention, Care and Treatment Partnership; the Government of the
Republic of Zambia (GRZ); the Global Fund for AIDS, Tuberculosis and Malaria (GFATM); UNITAID; and
the Clinton Foundation.
The purpose of this activity is to procure essential HIV/AIDS laboratory commodities in support of the
national ART program and to ensure that US Government (USG), GFATM, GRZ, and other partners'
HIV/AIDS laboratory commodity procurements are in sufficient supply and available at service delivery sites
through an efficient and accountable HIV/AIDS laboratory logistics and supply chain system.
In FY 2007, the USG, the World Bank, UNITAID, and GRZ provided funding for the procurement of
laboratory reagents to support the rapid scale-up of treatment and care for persons living with HIV/AIDS in
Zambia. Beginning in FY 2007 and continuing into FY 2008, the USG through SCMS, procured the
following items: CD4 reagents (Beckman Coulter Epics XL, Becton Dickinson FACSCalibur, Becton
Dickinson FACSCount, Guava Easy CD4 System (PCA)); hematology reagents (ABX Pentra 60C+, ABX
Micros 60, Sysmex pocH-100i); chemistry reagents (Cobas Integra 400, Ortho Vitros DT60, Olympus
AU400, Human Humalyzer 2000, Nova Biomedical Stat Profile pHOx Plus); and various consumables (e.g.,
Ethelyne Diamine Tetra Acetic Acid, vacutainer tubes, needles, disposable gloves and pipette tips).
To better ensure that these valuable commodities will be available in the correct condition, quantity, location
and time; SCMS has been working to improve the national HIV/AIDS laboratory logistics system through
technical assistance. A key component of this assistance was a series of workshops that led up to the
design of the new lab logistics system. The new system is a manual system that was implemented through
nationwide training. Both central level and service delivery site computer software logistics management
information systems and a central management information system that was installed at the Ministry of
Health (MOH) Logistics Management Unit.
In FY 2008, SCMS will continue to procure laboratory commodities in bulk. SCMS will procure 50% of the
national quantification for laboratory commodities; which will support the 2009 ART target of 230,000
patients. SCMS will also continue to strengthen and expand the national HIV/AIDS laboratory logistics
system through the following activities:
1) SCMS will quantify and procure USG-funded HIV/AIDS laboratory commodities consistent with
resources and policies for rapidly scaling-up HIV/AIDS clinical services;
2) SCMS will coordinate HIV/AIDS laboratory commodity forecasting efforts and will develop procurement
planning capacity within the MOH and with other key national stakeholders;
3) SCMS will standardize the HIV/AIDS laboratory commodity inventory control procedures at central,
district, and service delivery levels;
4) SCMS will implement a computerized HIV/AIDS laboratory logistics management information system
(LMIS) in at least 80 service delivery sites. For sites that are laboratories, the software development will be
in conjunction with ZPCT, the Centers for Disease Control (CDC), and the USAID | DELIVER PROJECT,
and its related mandate to improve HIV Test Logistics System;
5) SCMS will provide technical assistance and funding support for the creation of service and maintenance
contracts for laboratory equipment; which has been identified as a vital need by all stakeholders;
6) SCMS will develop and maintain a system for monitoring the function and condition of laboratory
equipment, providing an early warning system for the MOH when repairs or replacements are needed;
7) SCMS will develop and implement a specialized supply chain system for commodities with short shelf
8) SCMS will monitor and evaluate the HIV/AIDS laboratory supply chain as a whole, and will make
improvements and recommendations to the USG as needed.
To complete these activities, SCMS will collaborate with GRZ, GFATM Principal Recipients, and other
partners, to train up to 150 key personnel in the newly computerized national HIV/AIDS laboratory logistics
management system. Moreover, at the central level, SCMS will coordinate multi-year national HIV/AIDS
laboratory commodity forecasts and procurement plans with all key partners, including GRZ and donors.
SCMS will also be a key member of related national technical working groups, such as the Ministry of
Health's Procurement Technical Working Group and the HIV/AIDS Laboratory Committee.
Finally, in order to create a more sustainable HIV/AIDS laboratory commodity logistics system, SCMS will
continue to improve national capacity through training and skills transfer programming that is consistent with
the GRZ's vision of a fully-functioning national HIV/AIDS laboratory system.
All FY 2008 targets will be reached by September 30, 2009.
This activity links with USAID | DELIVER PROJECT's activities in Counseling and Testing (CT) and ARV
Drugs; the Partnership for Supply Chain Management Systems' (SCMS) activities in CT, ARV Drug, and
Laboratory Strengthening; the Centre for Infectious Disease Research in Zambia (CIDRZ); Catholic Relief
Services/AIDS Relief; Churches Health Association of Zambia (CHAZ); University Teaching Hospital (UTH);
Zambia Prevention, Care and Treatment Partnership (ZPCT); Government of the Republic of Zambia
(GRZ); Global Fund of AIDS, Tuberculosis and Malaria (GFATM); and the Clinton Foundation.
The purpose of this activity is to provide support to GRZ policy makers, the National HIV/AIDS/STI/TB
Council (NAC), the Ministry of Health (MOH), the Ministry of Finance and National Planning (MOFNP), and
other relevant stakeholders to implement the HIV/AIDS Commodity Security Strategy which has recently
been developed with assistance from SCMS and the USAID | DELIVER PROJECT.
The development and beginning implementation of a national HIV/AIDS Commodity Security Strategy was
based on a comprehensive HIV/AIDS Commodity Security (HACS) needs assessment conducted in
consultation with key MOH managers, policy makers, and cooperating partners. The process has provided
GRZ policy makers, NAC, donors, and other partners with a strategic plan detailing priority interventions to
better ensure a sustained, appropriate supply of essential HIV/AIDS commodities required for the
continuation of the national HIV/AIDS program following intensive PEPFAR support.
In FY 2007, the US Government (USG) authorized SCMS project core funds for the needs assessment and
the development of a national HIV/AIDS Commodity Security Strategic Plan. This strategy was developed
in close collaboration with GRZ, NAC, MOH, and other key stakeholders, such as CHAZ and the Clinton
Foundation. The first step in the process was to conduct an analysis of existing policies, procedures,
guidelines, and programs to identify commodity security issues that must be addressed in order to better
ensure the availability of key HIV/AIDS commodities (e.g., HIV test kits, ARV drugs, and laboratory
reagents), and a series of stakeholder meetings were held to seek support for the way forward. In FY 2007,
an implementation plan for the HIV/AIDS Commodity Security Strategic Plan was developed to foster local
ownership and to provide monitoring and evaluation of progress towards commodity security. Furthermore,
the newly formed national HIV/AIDS Commodity Security Working Group, representing 20 organizations,
was formed to ensure that activities are institutionalized and in accordance with the GRZ policies and
In FY 2008, SCMS will continue working with the HIV/AIDS Commodity Security Working Group and the 20
member organizations. In order to support the national HIV/AIDS Commodity Security Working Group,
formed under the MOH's leadership, and its implementation of the national strategy, SCMS will provide the
following assistance in FY 2008: 1) full-time support to the working group to ensure that the group remains a
viable entity; 2) continuous review, monitoring, and updating of the implementation of the HIV/AIDS
Commodity Security Strategy; 3) advocacy for HIV/AIDS Commodity Security at all levels of the health care
system (e.g., national, provincial, district, and community); 4) facilitate GRZ and donor coordination to
analyze and make recommendations to harmonize various inputs into the national HIV/AIDS procurement
systems; 5) enhance GRZ's commitment to provision of these essential commodities through increased
budgetary support; and 6) conduct a supplementary analysis identified in the strategy such as market
segmentation, ability to pay, and diversifying the funding base which would inform a longer term national
sustainability strategy that could be less dependent on donors for vital HIV/AIDS commodities.
The USG, GRZ, GFATM, Clinton Foundation, and other partners are committed to creating an environment
that will allow for the sustained availability of these critical supplies; long-term implementation of the
HIV/AIDS Commodity Security Strategic Plan will greatly assist in achieving this goal.
All FY 2008 targets will be reached by September 30, 2009.